NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
13 hedge funds and large institutions have $258K invested in InVivo Therapeutics Holdings Corp in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$62K | |
| 2 | +$2.22K | |
| 3 | +$2K | |
| 4 |
Morgan Stanley
New York
|
+$13 |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4 |
Top Sellers
| 1 | -$101K | |
| 2 | -$76K | |
| 3 | -$27K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$24K |
| 5 |
Two Sigma Advisers
New York
|
-$14K |